Luminex Posts 13 Percent Revenue Growth for Q1 | GenomeWeb

NEW YORK (GenomeWeb News) – Luminex reported after the close of the market Monday first-quarter revenue grown of 13 percent driven by a sharp uptick in assay revenues.

The Austin, Texas-based molecular diagnostics developer reported total revenues of $48.7 million for the quarter ended March 31, compared to revenues of $43.3 million for the first quarter of 2011. It beat Wall Street's consensus estimate of $48.2 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: new chromatin imaging approach, and more.

University of Wisconsin researchers uncover a mutation linked to Mauriac syndrome, which affects some children with type 1 diabetes.

Theranos has hired executives to oversee compliance and regulatory issues, the Wall Street Journal reports.

Chinese researchers to embark on a trial using a CRISPR/Cas9-based immunotherapy next month, Nature News reports.